Palantir Is The 'Next Oracle' On Trump-Backed AI Surge: Analyst

Wedbush analyst Daniel Ives raised Palantir Technologies' (PLTR) price target to $160 from $140, reiterating an Outperform rating, citing strong traction for its Artificial Intelligence Platform (AIP) across government and commercial sectors. Ives projects Palantir's U.S. commercial AI business could generate over $1 billion in annual revenue, driven by robust demand for AIP in both federal and commercial markets, including significant government initiatives like Project Stargate and a recent NATO contract. Despite a slight dip in PLTR shares post-announcement, the analyst views Palantir as a future dominant enterprise software player in the expanding AI market, suggesting the broader market may underestimate its long-term potential.

Analysis

Wedbush has raised its price target for Palantir Technologies (PLTR) to $160 from $140, reiterating an Outperform rating, based on accelerating traction for its Artificial Intelligence Platform (AIP). The upgrade is supported by a multi-faceted growth story, beginning with strong government-sector tailwinds, including U.S. initiatives like Project Stargate and a recent NATO contract that signals expanding influence in both U.S. and European defense sectors. A significant, and potentially underappreciated, component of the bull case is the commercial segment; the analyst projects Palantir's U.S. commercial AI business alone could surpass $1 billion in annual revenue. This commercial adoption is being accelerated by the company's 'bootcamps,' which are reportedly shortening sales cycles and speeding up deployment. While the analyst notes Palantir's current valuation appears elevated, he draws a parallel to Oracle's long-term potential, positioning PLTR as a prospective dominant force in the enterprise software market as AI spending increases. Despite this bullish outlook, PLTR shares traded down 0.56% to $142.36 on the day of the report.

Key Decisions for Investors

• Investors with a long-term bullish view on enterprise AI adoption should consider the analyst's upgraded $160 price target and the specified $1 billion+ U.S. commercial revenue potential as key validation points for Palantir's growth trajectory.
• Given the analyst's acknowledgement of an 'elevated' valuation, it is prudent to monitor for disciplined entry points, as the stock's current price is already trading above the previous target.
• Investors should track the quarterly performance of the commercial business segment and announcements of new government contracts as primary indicators to verify if the company is executing on the growth strategy outlined in this bullish thesis.